ENSYSCE BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.524 USD | -3.23% |
|
-6.60% | -50.57% |
| 21/03 | Transcript : Ensysce Biosciences, Inc., Q4 2023 Earnings Call, Mar 21, 2024 | |
| 15/03 | Ensysce Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Ensysce Biosciences, Inc.
28eb3d55b95ef57873a584dd97a45.fPaunkwIAyA_hgPLwV8TifiM_Rz-5YSRV_Jd2uTXAX0.PafBrXpQTnBd7nCjsxxeyr3ujF-0n7LrNpMQv4ihNEwKjP3oFnJtTgfFOw~da205c275d04bf799580127359abf4ce
Upcoming events on Ensysce Biosciences, Inc.
Past events on Ensysce Biosciences, Inc.
| 09/05/2024 | Q1 2024 Earnings Release (Projected) |
| 17/04/2024 11:30 pm | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
| 21/03/2024 08:30 pm | Business Update Call |
| 15/03/2024 05:30 pm | Q4 2023 Earnings Release |
| 09/03/2024 | American Association of Pain Medicine Meeting |
| 07/02/2024 | NIH HEAL Initiative Scientific Meeting |
| 20/12/2023 10:30 pm | Extraordinary Shareholders Meeting |
| 10/11/2023 03:00 am | Q3 2023 Earnings Release |
| 19/10/2023 | Pain Therapeutics Summit |
| 16/10/2023 | Fierce New Product Planning Summit |
| 11/09/2023 09:30 pm | H.C. Wainwright Global Investment Conference |
| 07/09/2023 | PAINWeek Scientific Symposium |
| 24/08/2023 09:30 pm | Annual General Meeting |
| 11/08/2023 05:30 pm | Q2 2023 Earnings Release |
| 24/07/2023 | Controlled Release Society Expo |
| 27/06/2023 | European Pharmaceutical Market Research Association Conference |
| 17/06/2023 | The College on Problems of Drug Dependence Scientific Meeting |
| 16/05/2023 02:00 am | Q1 2023 Earnings Release |
| 19/04/2023 09:00 pm | Business Update Call |
| 11/04/2023 08:30 pm | Business Update Call |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 3,53 2,90 21.77% | 2,52 2,64 -4.3% | 2,23 2,21 0.75% | 1,63 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -24,2 -21,9 -10.8% | -10,7 -10,9 1.23% | -19,7 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -19,9 -21,1 5.83% | -24,2 -22,8 -6.09% | -10,7 -10,9 1.23% | -19,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -29,1 -22,5 -29.54% | -24,2 -24,0 -0.68% | -10,6 -10,4 -1.75% | -19,8 |
|
Net income Million USD | Released Forecast Spread | 0,06 | -29,9 -22,4 -33.42% | -25,1 -24,3 -3.35% | -10,6 -10,4 -1.74% | -16,9 |
|
EPS USD | Released Forecast Spread | 0,00 | -355 -262 -35.78% | -139 -120 -16.01% | -4,69 -4,74 1.05% | -3,03 |
| Announcement Date | 15/03/21 | 31/03/22 | 30/03/23 | 15/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,64 1,00 63.53% | 0,60 1,20 -49.74% | 0,21 1,00 -79.25% | 0,28 1,00 -72.07% | 1,43 1,54 -6.92% | 0,79 0,95 -16.88% | 0,49 0,83 -40.67% | 0,44 0,59 -26.62% | 0,52 0,49 5.11% | 0,40 | 0,40 | 0,40 | 0,45 | 0,25 |
|
EBIT Million USD | Released Forecast Spread | -2,01 -3,20 37.29% | -4,80 -3,40 -41.26% | -7,06 -4,30 -64.07% | -6,16 -6,40 3.7% | -6,20 -5,80 -6.91% | -2,56 -5,60 54.26% | -2,29 -2,70 15.04% | -2,71 -2,50 -8.29% | -3,16 -2,80 -12.7% | |||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,0 -3,40 -195.21% | -0,95 -3,60 73.59% | -7,92 -4,50 -76.07% | -9,86 -6,40 -53.99% | -5,48 -5,80 5.55% | -2,19 -5,70 61.55% | -2,24 -2,70 17.06% | -2,69 -2,50 -7.63% | -3,52 -2,80 -25.59% | |||||
|
Net income Million USD | Released Forecast Spread | -10,8 -3,40 -218.83% | -1,67 -3,60 53.7% | -8,00 -4,50 -77.76% | -9,90 -6,40 -54.65% | -5,52 -5,80 4.79% | -2,20 -5,70 61.47% | -2,24 -2,70 17.19% | -2,69 -2,54 -5.74% | -3,50 -2,80 -25.15% | |||||
|
EPS USD | Released Forecast Spread | -108 -31,2 -246.15% | -14,4 -28,8 50% | -57,6 -40,8 -41.18% | -61,6 -38,4 -60.31% | -74,3 -28,9 -157.2% | -2,08 -5,08 59.03% | -0,98 -2,73 64.06% | -0,87 -1,06 17.67% | -1,37 -0,81 -69.14% | -0,90 | -0,73 | -0,71 | -0,69 | -0,60 |
| Announcement Date | 31/03/22 | 12/05/22 | 11/08/22 | 14/11/22 | 30/03/23 | 15/05/23 | 11/08/23 | 09/11/23 | 15/03/24 | - | - | - | - | - |
More events
Past sector events for Ensysce Biosciences, Inc.
| 10/05/2024 04:30 pm | HUMACYTE, INC.: Q1 2024 Earnings Release |
| 10/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release |
| 10/05/2024 | TAKARA BIO INC.: Q4 2023 Earnings Release |
| 10/05/2024 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 10/05/2024 01:40 am | GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | HILLEVAX, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | OMNIAB, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ENSC Stock
- Calendar Ensysce Biosciences, Inc.